
How real-world evidence can complement clinical investigations and help teams assess device performance across settings, populations and time.
Real-world evidence can show how a device performs in everyday clinical practice, beyond what clinical trials alone can tell us.
Clinical investigations answer defined questions under controlled conditions. Real-world evidence can add insight across broader populations, clinical settings, and longer periods.
Before market entry, teams need evidence to support safety, performance, and regulatory objectives.
Wider clinical use can raise new questions:
- Does performance remain consistent outside the original study environment?
- How is the device used across patient groups and clinical settings?
- What longer-term outcomes were difficult to observe during pre-market development?
Real-world evidence can help answer these questions.
Existing real-world data may also help teams understand disease pathways, patient populations, standards of care, and evidence gaps earlier in development.
That can shape the questions a clinical development program needs to answer.
Real-world datasets are collected for different purposes and under different conditions. Their usefulness depends on data quality, relevance to the question, and the decision they need to support.
Teams need to judge which questions real-world evidence can answer and which still require a purpose-designed clinical investigation.
As devices evolve, teams should assess pre-market findings alongside evidence from everyday clinical use.
Together, they can build a fuller picture of performance throughout a device's lifecycle.
Decide what you need to know about the device before deciding which data to collect.
